About BioJerusalem » Jerusalem's BioStrengths

Jerusalem's BioStrengths

Jerusalem possesses the essential components that contribute to the strength of the city's flourishing life sciences industry:

  • World class knowledge base in the life and biomedical sciences.
    This knowledge base is rooted in Jerusalem's leading academic, research and medical institutions, including: the Hebrew University of Jerusalem, Israel's foremost academic institution which is at the forefront of biotech and biomedical research; the Hadassah Medical Center, Israel's leading academic hospital that also specializes in clinical research; the Shaare Zedek Medical Center; and Jerusalem's technology colleges. All these provide a continuous flow of new inventions and ideas that fuel the city's technological innovation in the life and biomedical sciences.
  • Dynamic tech transfer activity headed by local TTOs.
    Yissum, the tech transfer company of the Hebrew University of Jerusalem, is positioned among the top 15 tech transfer companies in the world. The Hebrew University ranks 12th worldwide in biotech patents. Products derived from these patents generate annual sales of approximately $2 billion. Hadasit, the tech transfer company of the Hadassah Medical Center, is a powerhouse of startup activity focusing mainly on medical devices.
  • Highly skilled professional workforce in the life and biomedical sciences.
    More than 1,800 students graduate in life sciences annually from Jerusalem's academic institutions. Jerusalem also has the highest number of life sciences Ph.D. students in Israel. In addition, 3,500 people are employed by Jerusalem's life sciences companies, representing a significant proportion of the total workforce employed in technology based industry in the city. These populations combined provide an impressive technical and professional resource for the growing life sciences industry.
  • Unique biomedical R&D infrastructure.
    This includes state-of-the-art facilities and technology parks. Har Hotzvim Industrial Park is home to some of the biggest biopharma companies in Israel including Teva Pharmaceuticals, Rafa Laboratories, Sigma-Aldrich, Medinol, Omrix Biopharmaceuticals, that was acquired by Johnson & Johnson and Oridion Medical, that was acquired by Covidien. Of particular note is the Jerusalem BioPark at Ein-Kerem. Located nearby the Hadassah hospital and medical school, the BioMed Park solely hosts life sciences companies, enjoying the benefits of the rich infrastructure existing at the medical center. Jerusalem is also home to Bioline Innovations Jerusalem, Israel's only incubator that exclusively specializes in biotech and is devoted to accelerating drug development.
  • A valuable pool of life and biomedical sciences companies.
    In Jerusalem, theremore than 130 life sciences companiesranging from entrepreneurial start ups to more established biotech and medical device companies, as well as global pharma and medical device enterprises. There is a growing start-up sector, with about fifty percent of the life sciences companies at an early stage of development. Many of Jerusalem's life sciences companies are focused on the research and development of therapeutics for lucrative human healthcare applications. This pool of companies, with its large business potential, is a driving force boosting Jerusalem's economic growth and development.

In addition, technology-based companies and service providers established or expanding their business in Jerusalem can benefit from significant economic and financial incentives.